STAT3 and cancer: In the inflammatory TME, besides the activation of processes associated with cancer cell survival and proliferation, the ability of cancer cells to release cytokines and activate molecular pathways, as that of NF-kB or STAT-3, allows the subversion of the adaptive immune response, suppressing an effective antitumor immunity and inhibiting DC maturation [8].